Client News

Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim

Probiodrug and Alzheimer’s Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Program for PQ912

MorphoSys and I-Mab Biopharma Announce Initiation of Pivotal Phase 2 Study of TJ202/MOR202 for Multiple Myeloma

AiCuris plant sein weiteres Wachstum in Wuppertal

Medigene AG: Medigene presented paths to potential neoantigen-based TCR-therapies

Expedeon Announces Supervisory Board Changes

Molecular Health’s MH Guide shortlisted for the German Digital Health Award 2019

Abivax 2018 Financial Results and Operations Update

MorphoSys Presents Results for Fiscal Year 2018

Sterna biologicals holds Scientific Advisory Board meetings to advance phase IIb clinical development program of SB010 in asthma